Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ACTU
NEUP
Add up to 3 more stocks
ACTU
Actuate Therapeutics Inc
-7.24%
$0.81-0.06Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$19.42M
52W Range
$0.60 - $8.49
NEUP
Neuphoria Therapeutics Inc.
0.00%
$3.450.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$18.65M
52W Range
$3.19 - $21.40
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 19.63 | 0.76 |
| P/S Ratio | N/A | 15.88 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 43.5% |
| Operating Margin | 0.0% | -835.5% |
| Net Margin | 0.0% | -1578.4% |
| ROE | -2067.8% | -75.3% |
| ROA | -393.4% | -64.5% |
| ROIC | -1490.0% | -49.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.25 | 27.85 |
| Quick Ratio | 1.25 | 27.85 |
| Debt/Equity | 0.41 | 0.00 |
| Interest Coverage | -1110.88 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.